TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$30.26M2013: -$24.77M2014: -$79.81M2015: -$50.75M2016: -$58.21M2017: -$53.79M2018: -$80.04M2019: -$137.36M2020: -$176.16M2021: -$199.43M2022: -$319.81M2023: -$388.14M2024: -$323.83M2025: -$62.82M-$62.82M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$62.82M+80.6%
2024-$323.83M+16.6%
2023-$388.14M-21.4%
2022-$319.81M-60.4%
2021-$199.43M-13.2%
2020-$176.16M-28.2%
2019-$137.36M-71.6%
2018-$80.04M-48.8%
2017-$53.79M+7.6%
2016-$58.21M-14.7%
2015-$50.75M+36.4%
2014-$79.81M-222.2%
2013-$24.77M+18.1%
2012-$30.26M—